January 19, 2023Open Access

Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease

CGChristopher H. GibbonsLife University NWNingshan WangShihezi University SRSharika RajanNational Cancer Institute

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study provides Class II evidence that measurement of phosphorylated α-synuclein in skin biopsies can differentiate patients with MSA from those with PD.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Gibbons et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd1981854f360ad635996b https://doi.org/https://doi.org/10.1212/wnl.0000000000206772

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy2022 · 46 citations
2Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test1989 · 248 citations
3Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)2004 · 604 citations
4Staging of brain pathology related to sporadic Parkinson’s disease2002 · 10,807 citations
5Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis2022 · 70 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo